SEASTAR MEDICAL HOLDING CORP (ICU) Earnings History & Surprises
NASDAQ:ICU • US81256L3024
2.68 USD
-0.09 (-3.25%)
Last: Mar 12, 2026, 12:01 PM
Past quarterly earnings results for SEASTAR MEDICAL HOLDING CORP (ICU), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 25, 2026
PeriodQ4 / 2025
EPS Estimate-$1.07
Revenue Estimate376.225K
Last Reported
Release DateNov 13, 2025
PeriodQ3 / 2025
EPS Reported-$1.30
EPS Surprise 14.19%
Revenue Surprise -27.52%
Beat Rate
31%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -1.30 | -1.52 | 14.19% | -18.18% | 183K | 252.5K | -27.52% | 169.12% |
| Q2 2025 | -1.80 | -4.34 | 58.55% | -74.76% | 338K | 202K | 67.33% | - |
| Q1 2025 | -4.40 | -5.25 | 16.22% | 7.37% | 293K | 151.5K | 93.40% | - |
| Q4 2024 | -0.90 | -0.90 | -0.12% | 83.64% | 67K | 151.5K | -55.78% | - |
| Q3 2024 | -1.10 | -1.14 | 3.62% | 87.78% | 68K | 75.75K | -10.23% | - |
| Q2 2024 | -1.03 | -1.42 | 27.67% | 85.29% | 10.1K | -100.00% | - | |
| Q1 2024 | -4.75 | -3.79 | -25.41% | - | 151.5K | -100.00% | - | |
| Q4 2023 | -5.50 | -3.28 | -67.56% | - | - | - | ||
| Q3 2023 | -9.00 | -6.31 | -42.57% | - | - | - | ||
| Q2 2023 | -7.00 | -6.31 | -10.89% | - | - | - | ||
| Q1 2023 | - | - | - | - | ||||
| Q4 2022 | - | - | - | - | ||||
| Q3 2022 | - | - | - | - | ||||
| Q2 2022 | - | - | - | - | ||||
| Q1 2022 | - | - | - | - | ||||
| Q4 2021 | - | - | - | - | ||||
| Q3 2021 | - | - | - | - | ||||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
22.21%
Max EPS beat (4)
58.55%
Min EPS beat (4)
-0.12%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
19.36%
Max Revenue beat (4)
93.40%
Min Revenue beat (4)
-55.78%
Analysis
In the last 4 quarters, ICU has beaten EPS estimates in 3 out of 4 releases
ICU has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, ICU has beaten the EPS estimates by 22.2% on average.
In the last 4 quarters, ICU has beaten the revenue estimates by 19.4% on average.
SEASTAR MEDICAL HOLDING CORP / ICU Earnings FAQ
Can you provide the last earnings date for SEASTAR MEDICAL HOLDING CORP?
SEASTAR MEDICAL HOLDING CORP (ICU) last reported earnings on 11/13/2025.
Did ICU stock beat earnings estimates in the most recent quarter?
SEASTAR MEDICAL HOLDING CORP (ICU) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does ICU stock beat earnings estimates?
In the last 4 quarters, SEASTAR MEDICAL HOLDING CORP (ICU) has beaten EPS estimates in 3 out of 4 releases.